Literature DB >> 22029710

Serotonin-immunoreactive neurons and mast cells in the mouse esophagus suggest involvement of serotonin in both motility control and neuroimmune interactions.

C Hempfling1, W L Neuhuber, J Wörl.   

Abstract

BACKGROUND: Serotonin is a major transmitter in the gastrointestinal tract, but little is known about the serotonergic system in the esophagus.
METHODS: The aim of this study was to use multilabel immunofluorescence to characterize serotonin-positive nerve cell bodies and fibers and their relationship with other neuronal and non-neuronal elements in the mouse esophagus. Antibodies against serotonin, vesicular acetylcholine transporter (VAChT), choline acetyltransferase (ChAT), protein gene product 9.5 (PGP 9.5), and α-bungarotoxin (α-BT), were used. KEY
RESULTS: Serotonin-containing perikarya represented ∼10% of all PGP 9.5-positive myenteric neurons. Serotonin-positive varicose nerve fibers were found in the lamina muscularis mucosae and present on ∼13% of α-BT-labeled motor endplates in addition to VAChT-immunoreactive motor terminals. As ChAT-positive neurons of the compact formation of the nucleus ambiguus were negative for serotonin, serotonin-positive varicosities on motor endplates are presumed to be of enteric origin. On the other hand, cholinergic ambiguus neurons were densely supplied with serotonin-positive varicosities. The tela submucosa and tunica adventitia contained large numbers of serotonin-positive mast cells, a few of which were in close association with serotonin-positive nerve fibers. CONCLUSIONS & INFERENCES: The mouse esophagus is endowed with a rich serotonin-positive intrinsic innervation, including enteric co-innervation of striated muscles. Serotonin may modulate vagal motor innervation of esophageal-striated muscles not only at the central level via projections of the raphe nuclei to the nucleus ambiguus but also at the peripheral level via enteric co-innervation. In addition, mast cells represent a non-neuronal source of serotonin, being involved in neuroimmune processes.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22029710     DOI: 10.1111/j.1365-2982.2011.01797.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  10 in total

1.  Involvement of catecholaminergic neurons in motor innervation of striated muscle in the mouse esophagus.

Authors:  Piet van der Keylen; Fabian Garreis; Ruth Steigleder; Daniel Sommer; Winfried L Neuhuber; Jürgen Wörl
Journal:  Histochem Cell Biol       Date:  2016-01-21       Impact factor: 4.304

Review 2.  The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review.

Authors:  Wouter Schutyser; Ludovic Cruyt; Jean-Baptiste Vulsteke; Jan L Lenaerts; Ellen De Langhe
Journal:  Clin Rheumatol       Date:  2019-11-11       Impact factor: 2.980

3.  Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study.

Authors:  George P Karamanolis; Stylianos Panopoulos; Anastasios Karlaftis; Konstantinos Denaxas; Dimitrios Kamberoglou; Petros P Sfikakis; Spiros D Ladas
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

Review 4.  Enteric co-innervation of striated muscle in the esophagus: still enigmatic?

Authors:  Winfried L Neuhuber; Jürgen Wörl
Journal:  Histochem Cell Biol       Date:  2016-09-28       Impact factor: 4.304

Review 5.  Monoamines in the enteric nervous system.

Authors:  Winfried Neuhuber; Jürgen Wörl
Journal:  Histochem Cell Biol       Date:  2018-09-24       Impact factor: 4.304

6.  Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in women.

Authors:  Livia Sanna; Amanda L Stuart; Michael Berk; Julie A Pasco; Paolo Girardi; Lana J Williams
Journal:  BMC Psychiatry       Date:  2013-07-24       Impact factor: 3.630

7.  The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.

Authors:  George P Karamanolis; Stylianos Panopoulos; Konstantinos Denaxas; Anastasios Karlaftis; Alexandra Zorbala; Dimitrios Kamberoglou; Spiros D Ladas; Petros P Sfikakis
Journal:  Arthritis Res Ther       Date:  2016-09-01       Impact factor: 5.156

8.  Study on the relationship of depression, anxiety, lifestyle and eating habits with the severity of reflux esophagitis.

Authors:  Rongxin Wang; Jing Wang; Shuiqing Hu
Journal:  BMC Gastroenterol       Date:  2021-03-20       Impact factor: 3.067

9.  Buccal Buspirone as add-on Therapy to Omeprazole Versus Omeprazole in Treatment of Gastroesophageal Reflux Diseases (GERD).

Authors:  Saeed Abdi; Zahra Sargashteh; Mohammad Abbasinazari; Jamshid Salamzadeh; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

10.  Tryptophan Metabolites as Biomarkers for Esophageal Cancer Susceptibility, Metastasis, and Prognosis.

Authors:  Yun Chen; Jianliang Chen; Dainian Guo; Peixuan Yang; Shuang Chen; Chengkuan Zhao; Chengcheng Xu; Qiuzhen Zhang; Chaoxian Lin; Shilong Zhong; Shuyao Zhang
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.